Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4

Societal savings in patients with advanced non-squamous non-small-cell lung cancer receiving bevacizumab-based versus non-bevacizumab-based treatments in France, Germany, Italy, and Spain

Total article views   HTML views PDF downloads Totals
11,840 Dovepress* 10,730+ 1,842 12,572
PubMed Central* 1,110 317 1,427
Totals 11,840 2,159 13,999
*Since 4 October 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 0 4

View citations on PubMed Central and Google Scholar